The complotype: dictating risk for inflammation and infection
about
Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis.A humanized antibody that regulates the alternative pathway convertase: potential for therapy of renal disease associated with nephritic factorsComplement regulation in renal disease modelsNovel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.Complement in disease: a defence system turning offensiveNew milestones ahead in complement-targeted therapy.Complement modulates the cutaneous microbiome and inflammatory milieu.Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN.Functional analysis of a complement polymorphism (rs17611) associated with rheumatoid arthritisRare loss-of-function mutation in complement component C3 provides insight into molecular and pathophysiological determinants of complement activityRare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levelsComplement activation, regulation, and molecular basis for complement-related diseasesComplement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention.The Genetics of Ultra-Rare Renal Disease.Complement component C3 - The "Swiss Army Knife" of innate immunity and host defenseFrom orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage.Structural Implications for the Formation and Function of the Complement Effector Protein iC3b.Complement Polymorphisms in Kidney Transplantation: Critical in Graft Rejection?Innate Immunity in Systemic Sclerosis.Complement C3-Targeted Therapy: Replacing Long-Held Assertions with Evidence-Based Discovery.Complement Factor H Serum Levels Determine Resistance to Pneumococcal Invasive Disease.Disease-linked mutations in factor H reveal pivotal role of cofactor activity in self-surface-selective regulation of complement activation.A Novel Complotype Combination Associates with Age-Related Macular Degeneration and High Complement Activation Levels in vivo.The renaissance of complement therapeutics.Calcineurin inhibitor-induced complement system activation via ERK1/2 signalling is inhibited by SOCS-3 in human renal tubule cells.C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.Expanding horizons in complement drug discovery: challenges and emerging strategies.Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy.Association Between Promoter Polymorphisms in CD46 and CD59 in Kidney Donors and Transplant Outcome.The complement system contributes to functional antibody-mediated responses induced by immunization with Plasmodium falciparum malaria sporozoites.Atypical hemolytic uremic syndromeThrombotic microangiopathy after renal transplantation: Current insights in and recurrent diseaseBe on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated DiseasesReference Intervals of Factor H and Factor H-Related Proteins in Healthy ChildrenCutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in
P2860
Q30275101-10101167-6CC1-4889-ACC2-20F4C3D02FD1Q30409539-D815D614-6AD5-4CA2-BC57-9B11A4EF7564Q33411137-0025E40E-B402-4DA9-B918-455657B7923FQ33417375-196305EF-47B1-441D-B7D2-1BFA50D2A2D9Q33432423-36C32869-F05F-4FC5-B529-E657AB254A0FQ33602320-ACAA5F33-1018-4B99-B7C9-9375BF89BF99Q34366931-4CD393B3-3228-497C-A9C7-91D77845D971Q34427591-E3DD1E2C-DA38-4CFE-9044-170999FF416AQ35199125-C6A080D2-4D70-4969-AE36-A01AD38EB42FQ35205450-BF85829E-1D19-4780-92A8-6D24BA218A11Q35693886-F4D0D57E-D200-4CA0-A269-85E5A6025F70Q36380682-4AE99BB0-D7B2-411E-8022-71993056D60AQ36460034-2CEE622A-6F50-4081-B69D-4BC61522E6D7Q37032691-A79CEA87-4695-43BD-A2C2-3D43435C854AQ38558926-8D50F3C1-7E73-4ED4-BDC2-9673E594E70EQ38879877-B197CE07-8463-49FC-9828-0D5379D4CE07Q38930517-3BB56941-BD05-4CD4-9554-5D9904A78E0FQ39093267-35F764EB-D041-4247-902B-836B2D169E06Q39100157-1EEB0CFF-1541-4B56-B76D-7DB790D258D9Q39246952-258D50A4-5175-4D99-A7F4-74E1341A9AB0Q40821027-F557F301-70DF-475A-BCE8-8B5D60F29155Q41377869-EBD0C8B3-56B9-4D0C-A5A3-67C29FFDFFF9Q42119687-50B3CEBA-D9B6-4779-995D-792FED7A5544Q47336749-90247AFA-9896-41FE-BA6C-85F7D1593EF9Q47588581-1CA50E9D-13B4-46F0-96F5-281F05D2E535Q47909388-775D38F2-A494-4E11-B293-BD91ED4938CAQ49439487-D88B76C5-EF25-46C4-8C85-F89B35B24C5EQ51568998-157B4136-B0CF-4DDC-8901-91775A69280DQ54967868-76AEBB5F-18B3-42ED-BE85-68FAA393CA12Q55353878-6278D767-B83F-4498-BB29-DE0D471923CAQ56591965-6546BAB1-E31A-412A-813B-D321BF4464B6Q58754943-FC5D6EBC-4833-4D85-8254-B8681004E287Q58795472-7C2E0788-938A-4D0F-8162-8A23A489C82EQ58803464-5C563800-3E15-41CF-A8A7-D3FB8A6E9F4BQ59132967-97DD051E-F4C0-44D0-AF81-A2B07A434805
P2860
The complotype: dictating risk for inflammation and infection
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The complotype: dictating risk for inflammation and infection
@ast
The complotype: dictating risk for inflammation and infection
@en
The complotype: dictating risk for inflammation and infection
@nl
type
label
The complotype: dictating risk for inflammation and infection
@ast
The complotype: dictating risk for inflammation and infection
@en
The complotype: dictating risk for inflammation and infection
@nl
prefLabel
The complotype: dictating risk for inflammation and infection
@ast
The complotype: dictating risk for inflammation and infection
@en
The complotype: dictating risk for inflammation and infection
@nl
P2093
P2860
P3181
P356
P1433
P1476
The complotype: dictating risk for inflammation and infection
@en
P2093
B. Paul Morgan
Claire L. Harris
Meike Heurich
Santiago Rodriguez de Cordoba
P2860
P304
P3181
P356
10.1016/J.IT.2012.06.001
P407
P577
2012-10-01T00:00:00Z